Navigation Links
R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
Date:9/10/2007

ctions. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidates. Clevudine, for the treatment of chronic HBV infection, is expected to enter Phase 3 clinical trials for registration in the Americas and Europe. Clevudine is already approved for HBV in South Korea and marketed by Bukwang Pharmaceuticals under the brand name Levovir. R7128, an oral treatment for chronic HCV infection, is in a Phase 1 clinical trial through a strategic collaboration with Roche. Racivir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial.

About R7128

R7128 is being developed for the treatment of chronic hepatitis C. R7128 is a prodrug of PSI-6130, which demonstrated potency in preclinical studies. PSI-6130 is a pyrimidine nucleoside analog inhibitor of HCV RNA polymerase, an enzyme that is necessary for hepatitis C viral replication. Results from an oral single ascending dose study of PSI-6130 in 24 healthy male volunteers showed that PSI-6130 was generally well tolerated with no serious adverse events in doses up to 3000 mg.

R7128 Phase 1 Study Overview

The Phase 1 clinical trial is a multiple center, observer-blinded, randomized and placebo-controlled study to investigate the pharmacokinetics, pharmacodynamics, safety, tolerability and food effect of R7128 in healthy volunteers and in patients chronically infected with HCV genotype 1. This Phase 1 study is comprised of two parts:

- Part 1 is a single ascending dose study of R7128 conducted in 46

healthy volunteers. The primary objective of Part 1 is to assess the

safety, tolerability and pharmacokinetics of R7128 following single

ascending doses under fasting conditions. The secondary objective of

P
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
4. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
5. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
6. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
7. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
8. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
9. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
10. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... and SOUTHAMPTON , ... pharmaceutical company Pharmaxis Ltd (ASX: PXS) and UK biotechnology company ... a research collaboration to develop a selective inhibitor to the ... lung disease idiopathic pulmonary fibrosis (IPF). IPF ... Current products are expected to produce global revenues in excess ...
(Date:8/4/2015)... On August 3, 2015, a press conference on anti-virus and ... ceremony of a million masks by Wuhan Longfeixiang Technology Products ... . Wuhan Longfeixiang Technology Products ... Longfeixiang Industrial Group, which has successfully developed the globally ... mask, filling the global gap for masks of this ...
(Date:8/4/2015)... Aug. 4, 2015 Young Innovations ("Young"), ... equipment, today announced the acquisition of the professional ... Inc. ("MPL PDCMD"). MPL PDCMD manufactures fluoride varnish, ... and restorative dental procedures. "This ... business in attractive, high-growth segments," said Dave ...
Breaking Medicine Technology:Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 3Young Innovations Announces Acquisition of Medical Products Laboratories' Professional Dental Contract Manufacturing Division 2
(Date:8/4/2015)... (PRWEB) , ... August 05, 2015 , ... ... Deborah Stevens as a 2015-2016 inductee into its VIP Woman of ... business. NAPW is the nation’s leading networking organization exclusively for professional women, boasting ...
(Date:8/4/2015)... ... 04, 2015 , ... Sponsored by Gila River Casinos, the charity event helps ... organization. , According to the New Foundation AZ spokesperson , the organization is ... includes a complimentary foursome for the tournament, as well as getting their company advertised ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... focused on sexual and reproductive health and rights in Indonesia for a select ... visit a number of sites in Indonesia and attend the International Conference on ...
(Date:8/4/2015)... ... August 04, 2015 , ... Ryadon ... customers. Finding reliable hardware can be difficult and troublesome for companies. ... office together or designing a new facility, it is imperative to include only ...
(Date:8/4/2015)... ... 2015 , ... Worldwide Power Products acquires new assets, certifying ... in Texas. Effective July 1st of this year, Worldwide Power Products acquired operations ... the North Texas acquisition, Worldwide Power Products (“WPP”) now services 1000 generators in ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:North Texas Acquisition Press Release 2
... Management Fundamentals for Healthcare module is now available online ... Georgia Center for Continuing Education,s Healthcare Management Certificate ... experience hands-on application to a work-related project, and learn ... efficient techniques for managing projects in a healthcare environment. ...
... State to Win Honor PITTSBURGH, May 14 MSA ... employee Wellness Program has received the "Gold Well Workplace ... is the first company headquartered in Pittsburgh, and just ... this fashion by demonstrating outstanding quality and excellence in ...
... voriconazole to its YeastOne(R) susceptibility plate for ... FDA-cleared antifungal agents- New Research-Use-Only Sensititre(R) Xtra ... including colistin and polymixin BCLEVELAND, May 14 ... company and premier provider of diagnostic systems ...
... time leg, foot or hand cramps can now get instant relief. ... has made it available for the first time via the Internet. ... pregnant women suffering from night time leg cramps, the problem is ... to be kept awake for hours during the night. This old ...
... Remind People to Eliminate Standing Water to Reduce Risk ... reported the first finding of West Nile Virus in ... and reminded residents of steps they can take to ... mosquito. The Department of Environmental Protection,s West Nile Virus ...
... play a role in heart muscle rejuvenation by attracting cells ... have been successfully used to halt or reverse cardiac injury ... occurs. , A new study that delivered embryonic stem ... found that the resulting mice demonstrated a capacity to recover ...
Cached Medicine News:Health News:New Online Project Management Fundamentals for Healthcare Module Available 2Health News:Wellness Program at MSA Receives National Recognition 2Health News:Wellness Program at MSA Receives National Recognition 3Health News:TREK to Introduce New In Vitro Diagnostic and Research-Use-Only Susceptibility Products at American Society for Microbiology General Meeting, Booth 1301 2Health News:TREK to Introduce New In Vitro Diagnostic and Research-Use-Only Susceptibility Products at American Society for Microbiology General Meeting, Booth 1301 3Health News:TREK to Introduce New In Vitro Diagnostic and Research-Use-Only Susceptibility Products at American Society for Microbiology General Meeting, Booth 1301 4Health News:Amish Formula From Caleb Treeze Organic Eliminates Night Time Cramps 2Health News:PA's First West Nile Positive Sample of 2009 Discovered in York County 2Health News:PA's First West Nile Positive Sample of 2009 Discovered in York County 3Health News:Stem cell transplant in mouse embryo yields heart protection in adulthood 2
Modified Freer periosteal elevator, #163, slight curve, 21 cm....
Steinhauser periosteal elevator....
Albjerg periosteal elevator, light, 6 mm handle, 17.5 cm, 7"....
Periosteal elevator #9, 18 cm, 7"....
Medicine Products: